We are live on
!
Find out more
NCM
Northroad Capital Management Portfolio holdings
AUM
$43.8M
1-Year Est. Return
163.34%
This Fund
S&P 500
This Quarter
Est. Return
-1.44%
1 Year Est. Return
+163.34%
3 Year Est. Return
+160.29%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$258M
AUM Growth
–
Cap. Flow
+$267M
Cap. Flow
% of AUM
103.51%
Top 10 Holdings %
Top 10 Hldgs %
32.86%
Holding
56
New
56
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$12.3M |
| 2 |
TotalEnergies
TTE
|
+$9.75M |
| 3 |
Sanofi
SNY
|
+$8.8M |
| 4 |
GSK
GSK
|
+$8.53M |
| 5 |
HSBC
HSBC
|
+$7.63M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.02% |
| 2 | Technology | 11.34% |
| 3 | Energy | 10.27% |
| 4 | Financials | 8.75% |
| 5 | Consumer Staples | 8.39% |
Similar funds
CC
RAM
ACI
QCM
NHG
RVGI
BS
BSCM
Northroad Capital Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Northroad Capital Management, which disclosed 56 positions worth $258M. Its ten largest holdings account for 33% of the portfolio.
Its largest position is Novartis: 189,106 shares worth $12M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, followed by Technology and Energy.
- Northroad Capital Management's largest Q2 2013 buy was Novartis: 189,106 shares worth $12M.
- Northroad Capital Management's ten largest holdings make up 33% of its $258M portfolio in Q2 2013.
- Northroad Capital Management disclosed 56 positions in Q2 2013, its first 13F filing on record.
Based on Northroad Capital Management's 13F filing for Q2 2013, filed 31 Jul 2013.